Mitigating diabetes-related complications: Empowering metformin with cholecalciferol and taurine supplementation in type 2 diabetic rats

Figure 7 Examination of histopathological changes in rat liver sections using HE staining. Photomicrographs of different magnifications showing pancreatic sections of the control group (A and B), Streptozotocin diabetic group (C and D), metformin (MET)-treated group (E and F), cholecalciferol (CHO) + MET-treated group (G and H), taurine (TAU) + MET-treated group (I and J), and TAU + CHO + MET-treated group (K and L). ¹The central vein. ²Lobular inflammation. ³Fibrous portal expansion. ⁴Sinusoidal dilatation. ⁵Hydropic degeneration. ⁶Preserved hepatocyte arrangement with binucleation of some hepatocytes. ⁷Hydropic degeneration of hepatocytes with areas of necrosis indicated by lost nuclei.